Triin Jurgenson

Triin Jurgenson is a Protein Expression Scientist I at ADC Therapeutics, with experience in designing and creating plasmids for recombinant protein expression in suspension CHO/HEK cells, optimizing protein titer and quality, and generating stable cell lines, as well as large-scale bioprocessing. Previously, Triin worked as a Bioconjugation Scientist I at ADC Therapeutics, focusing on novel conjugations for ADC toxins, and as a Bioconjugation Scientist at Antikor Biopharma Ltd, where responsibilities included screening and documenting ADC and FDC conjugations and analyzing methods for DAR determination. Triin's earlier roles include Process Development Scientist at ADC Biotechnology Ltd, where process optimization for ADC synthesis and purification was a primary focus, and medical laboratory assistant at NHS. Triin holds a Master's degree in Molecular Medicine from The University of Sheffield, a Higher National Diploma in Applied Biology from Bournemouth and Poole College, and a Bachelor's degree in Economics from Royal Holloway, University of London.